Atlas Trials

Phase I/II Study of Nab-paclitaxel and Gemcitabine Followed by AG-mFOLFOX in Patients With Metastatic Pancreatic Adenocarcinoma

Clinical trial NCT02504333 · COMPLETED

Trial details

NCT number
NCT02504333
Sponsor
Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Metastatic Pancreatic Adenocarcinoma
Start date
2015-07-01
Primary completion
2021-04-01
Enrollment
168

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.